Actavis Hormonal Contraceptive Device Wins FDA Approval
Feb 27 (Reuters) - The U.S. Food and Drug Administration approved a hormonal contraceptive device on Friday that gives American women another reversible contraceptive choice as effective as sterilization.
The intrauterine device (IUD) device, Liletta, releases the hormone levonorgestrel to inhibit thickening of the womb lining, preventing pregnancy for up to three years.
Help employers find you! Check out all the jobs and post your resume.
The intrauterine device (IUD) device, Liletta, releases the hormone levonorgestrel to inhibit thickening of the womb lining, preventing pregnancy for up to three years.
Help employers find you! Check out all the jobs and post your resume.